文献速递外周动脉疾病

衰弱与外周动脉疾病血运重建后无住院日减少相关

Frailty is associated with fewer hospital-free days following peripheral artery disease revascularization.
PubMed 文献 · J Vasc Surg · 2026-07-08

该回顾性研究纳入11436例因外周动脉疾病行下肢血运重建的成人,采用适应ICD-10-CM的衰弱风险分析指数定义衰弱(≥36分)。多变量调整后,衰弱患者90天内无住院日调整率比为0.95(95%CI 0.94-0.97),对应调整后无住院日76天 vs 80天,且衰弱与更高的截肢和死亡风险相关。

要点

  • 衰弱患者血运重建后90天无住院日更少,调整后为76天 vs 80天。
  • 衰弱与 major amputation 风险升高相关(aHR 1.44)。
  • 衰弱与死亡风险升高相关(aHR 1.69),但 major reintervention 风险较低。

核心结论

  • 在外周动脉疾病行下肢血运重建的患者中,衰弱与90天内无住院日减少独立相关。
  • 衰弱对肢体结局和死亡结局有不良影响,尤其在术后早期。

研究设计与样本

  • 多医院医疗系统内2016-2024年因外周动脉疾病行首次下肢血运重建的成人回顾性分析。
  • 共纳入11436例成人,年龄71.1±0.3岁,62%男性,67%白人,17%为衰弱。
  • 衰弱通过适应ICD-10-CM的衰弱风险分析指数定义:不衰弱<36分,衰弱≥36分。
  • 主要结局为术后90天内无住院日,定义为存活且不在住院急性医院或急诊就诊的总天数。

主要发现

  • 衰弱患者观察到的中位无住院日最低:83天(IQR 73-88) vs 86天(IQR 80-89)。
  • 调整后平均无住院日:衰弱组76天(95%CI 75-77),非衰弱组80天(95%CI 79-80)。

临床怎么用

  • 建议对行下肢血运重建的外周动脉疾病患者常规进行衰弱筛查。
  • 对衰弱患者应加强围手术期照护规划,并利用此类数据支持医患共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Many patients with peripheral artery disease (PAD) are frail and experience an increased risk of adverse outcomes, regardless of revascularization status. Hospital-free days (HFDs) represent an important patient-centered outcome as it accounts for both the early- and long-term utilization of hospital and emergency department care, as well as survival. We hypothesized that frail patients would experience fewer HFDs after lower-extremity revascularization for PAD. METHODS: We performed a retrospective analysis of adults undergoing an index lower-extremity revascularization for PAD (2016-2024) in a multihospital health care system. We defined frailty via the Risk Analysis Index adapted to the International Statistical Classification of Diseases, 10th Revision, Clinical Modification: not frail (<36) and frail (≥36). We defined our primary outcome, HFDs, as total days alive and outside of inpatient acute hospitals or emergency department visits, in a 90-day postoperative interval. Patients who died during the interval accrued zero additional HFDs after death. We modeled the association between frailty and PAD on HFDs using negative binomial regression, adjusting for age, demographics, and pertinent comorbidities not within the Risk Analysis Index. We generated adjusted rate ratios and 95% confidence intervals (CIs), as well as marginal adjusted mean HFDs. We compared secondary outcomes, including time-to-major amputation, major reintervention, and mortality using Kaplan-Meier curves and Cox models. RESULTS: In total, 11,436 adults (age, 71.1 ± 0.3 years; 62% male, 67% White) underwent revascularization for PAD, of which 17% were frail. Frail patients were more commonly older, men, and with comorbid diabetes, as well as pulmonary and coronary artery disease. Observed median HFDs was lowest among the frail patients (83 days [interquartile range, 73-88] vs 86 days [interquartile range, 80-89]) with PAD. On multivariable adjustment, the rate of HFDs was lower among frail patients (adjusted rate ratio, 0.95; 95% CI, 0.94-0.97; P = .01), which corresponded to 76 (95% CI, 75-77) vs 80 (95% CI, 79-80) adjusted HFDs in the 90 days after reintervention. Further, after multivariable Cox modeling, frailty was associated with a higher risk of major amputation [adjusted hazard ratio (aHR), 1.44; 95% CI, 1.12-1.84; P = .004] and mortality (aHR, 1.69; 95% CI, 1.49-1.92; P = .01), but a lower risk of major reintervention (aHR, 0.78; 95% CI, 0.64-0.94; P < .001). CONCLUSIONS: Among patients with PAD undergoing lower-extremity revascularization, frailty was associated with fewer HFDs. Frailty adversely affects limb and mortality outcomes, especially in the early postoperative period, reiterating the need for routine frailty screening, advanced perioperative care planning, and using data like these to inform shared decision-making between patient and clinicians.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Iyer S, Nassereldine H, Kennedy JN, et al. Frailty is associated with fewer hospital-free days following peripheral artery disease revascularization. J Vasc Surg. 2026. PMID: 42413744. doi:10.1016/j.jvs.2026.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。